BNP Paribas Financial Markets’s Foundation Medicine, Inc. FMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-777
| Closed | -$106K | – | 4542 |
|
|
2018
Q2 | $106K | Sell |
777
-2,268
| -74% | -$206K | ﹤0.01% | 2760 |
|
|
2018
Q1 | $240K | Buy |
3,045
+28
| +0.9% | +$2.07K | ﹤0.01% | 2693 |
|
|
2017
Q4 | $206K | Buy |
3,017
+1,596
| +112% | +$82.8K | ﹤0.01% | 2945 |
|
|
2017
Q3 | $57.1K | Sell |
1,421
-94
| -6% | -$3.63K | ﹤0.01% | 3082 |
|
|
2017
Q2 | $60.2K | Buy |
1,515
+1,430
| +1,682% | +$52.4K | ﹤0.01% | 3092 |
|
|
2017
Q1 | $2.74K | Sell |
85
-669
| -89% | -$16.7K | ﹤0.01% | 3451 |
|
|
2016
Q4 | $13.3K | Sell |
754
-242
| -24% | -$5.21K | ﹤0.01% | 3337 |
|
|
2016
Q3 | $23.3K | Buy |
996
+400
| +67% | +$9.08K | ﹤0.01% | 2801 |
|
|
2016
Q2 | $11.1K | Buy |
596
+495
| +490% | +$8.95K | ﹤0.01% | 2861 |
|
|
2016
Q1 | $1.84K | Sell |
101
-2,451
| -96% | -$39.5K | ﹤0.01% | 2424 |
|
|
2015
Q4 | $53.7K | Sell |
2,552
-637
| -20% | -$12.3K | ﹤0.01% | 2765 |
|
|
2015
Q3 | $58.8K | Buy |
3,189
+1,610
| +102% | +$40.2K | ﹤0.01% | 2743 |
|
|
2015
Q2 | $53.4K | Buy |
1,579
+1,253
| +384% | +$50.4K | ﹤0.01% | 2456 |
|
|
2015
Q1 | $15.7K | Buy |
+326
| New | +$14.8K | ﹤0.01% | 2491 |
|
|
2014
Q4 | – | Sell |
-998
| Closed | -$18.9K | – | 3699 |
|
|
2014
Q3 | $18.9K | Buy |
+998
| New | +$23.8K | ﹤0.01% | 3210 |
|
|
2014
Q2 | – | Sell |
-96
| Closed | -$2.8K | – | 4027 |
|
|
2014
Q1 | $2.8K | Buy |
96
+12
| +14% | +$390 | ﹤0.01% | 2564 |
|
|
2013
Q4 | $2K | Buy |
+84
| New | +$2.35K | ﹤0.01% | 3653 |
|
BNP Paribas Financial Markets's FMI Position: Q3 2018 in Review
BNP Paribas Financial Markets sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 777 shares — an estimated $106K sold.
BNP Paribas Financial Markets first reported a position in FMI in Q4 2013 and held it in 17 quarters. The position peaked at $240K in Q1 2018. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.
- BNP Paribas Financial Markets reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
- BNP Paribas Financial Markets sold 777 Foundation Medicine, Inc. shares in Q3 2018, an estimated $106K.
- BNP Paribas Financial Markets first reported a position in Foundation Medicine, Inc. in Q4 2013 and held it in 17 quarters.
- BNP Paribas Financial Markets's Foundation Medicine, Inc. position peaked at $240K in Q1 2018.
- 0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2018, filed 7 Nov 2018.